Problems in the structure of clinical trials

Bookmark and Share
Published: 21 May 2012
Views: 4223
Prof Thomas Tursz – Institut Gustave Roussy, Paris, France

Prof Thomas Tursz talks to ecancer about the movement towards personalised medicine and the current problems in clinical trials in Berlin, May 2012.


The movement towards personalised medicine indicates a need for reorganisation in clinical trials. In clinical trials, 97% of patients in Europe are not in a trial. These patients are at a disadvantage because the process of joining a clinical trial involves a much more thorough analysis of their disease. Data shows that patients in clinical trials have better outcomes than those not in them.